About LOCUS BIOSCIENCES INC
Locus Biosciences is a precision medicine company developing engineered bacteriophage therapies for infectious diseases and immunology. The company uses AI, robotics, and synthetic biology to create targeted treatments that remove pathogenic bacteria without disrupting the microbiome.
Development of engineered bacteriophage therapiesAI-driven cocktail prediction toolsState-of-the-art robotics and automated biobankingSynthetic biology techniquesWorld-class viral vector manufacturing facility producing cGMP clinical trial materialPrecision medicine for bacterial infections and immunologic diseases
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| CLINICAL DEVELOPMENT OF CRISPR-CAS3 PHAGE COCKTAIL FOR THE TREATMENT OF RECURRENT URINARY TRACT INFECTIONS CAU | Department of Health and Human Services | $73.9M | |
| ADVANCE A NOVEL THERAPEUTIC TO A FIRST-IN-HUMAN CLINICAL STUDY | Department of Health and Human Services | $7.9M |
Teaming History
Prime contractors LOCUS BIOSCIENCES INC has worked under:
- Trustees Of Boston University — 15 subcontract(s)
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to LOCUS BIOSCIENCES INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.